Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06615739 · ClinicalTrials.gov registry record

Comprehensive SRS Regenerex Tissue Attachment

A clinical trial of Arthroplasty Complications and Osteo Arthritis Shoulders, sponsored by Zimmer Biomet.

Active
Registry status
22
Enrollment target
1
Study location

NCT06615739 is a study of Arthroplasty Complications and Osteo Arthritis Shoulders that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 22 participants, below the 588-participant average among 5 other Arthroplasty Complications trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06615739, a study of Arthroplasty Complications and Osteo Arthritis Shoulders, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

Interventions

  • DEVICE Regenerex Tissue Attachment Augments

Study Locations (1)

Florida

  • Toman Orthopedics and Sports Med - Boca Raton

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-10-22
Est. Completion 2026-12-31

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT06615739

The ClinicalTrials.gov registry entry for NCT06615739 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 588-participant average among 5 other Arthroplasty Complications trials with a reported enrollment target (96% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Arthroplasty Complications appearing as the primary indexed condition, and to 1 intervention - of which Regenerex Tissue Attachment Augments is the first listed.

NCT06615739 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06615739 about?

NCT06615739 is a clinical study titled "Comprehensive SRS Regenerex Tissue Attachment". The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

What is the current status of trial NCT06615739?

This trial is currently active not recruiting. The enrollment target is 22 participants. The study started on 2024-10-22. Estimated completion is 2026-12-31.

What conditions does trial NCT06615739 study?

This clinical trial studies the following conditions: Arthroplasty Complications, Osteo Arthritis Shoulders.

What interventions are being tested in trial NCT06615739?

The interventions under investigation include: Regenerex Tissue Attachment Augments (DEVICE).

Who is sponsoring clinical trial NCT06615739?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06615739 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthroplasty Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.